Phenotypic, chemical and functional characterization of cyclic nucleotide phosphodiesterase 4 (PDE4) as a potential anthelmintic drug target.
Reliance on just one drug to treat the prevalent tropical disease, schistosomiasis, spurs the search for new drugs and drug targets. Inhibitors of human cyclic nucleotide phosphodiesterases (huPDEs), including PDE4, are under development as novel drugs to treat a range of chronic indications includi...
Saved in:
Main Authors: | Thavy Long (Author), Liliana Rojo-Arreola (Author), Da Shi (Author), Nelly El-Sakkary (Author), Kurt Jarnagin (Author), Fernando Rock (Author), Maliwan Meewan (Author), Alberto A Rascón (Author), Lin Lin (Author), Katherine A Cunningham (Author), George A Lemieux (Author), Larissa Podust (Author), Ruben Abagyan (Author), Kaveh Ashrafi (Author), James H McKerrow (Author), Conor R Caffrey (Author) |
---|---|
Format: | Book |
Published: |
Public Library of Science (PLoS),
2017-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Inhaled Phosphodiesterase 4 (PDE4) Inhibitors for Inflammatory Respiratory Diseases
by: Jonathan E. Phillips
Published: (2020) -
Type-4 Phosphodiesterase (PDE4) Blockade Reduces NETosis in Cystic Fibrosis
by: Licia Totani, et al.
Published: (2021) -
Sex-differential genetic effect of phosphodiesterase 4D (PDE4D) on carotid atherosclerosis
by: Guo Yuh-Cherng, et al.
Published: (2010) -
Population genetics of PDE4B (phosphodiesterase‐4B) in neglected Native Americans: Implications for cancer pharmacogenetics
by: Rennan Garcias Moreira, et al.
Published: (2022) -
Validated stability-indicating HPLC-DAD method for determination of the phosphodiesterase (PDE-4) inhibitor roflumilast
by: Tarek S. Belal, et al.
Published: (2014)